Dudediligence.

Structure Therapeutics Inc

GPCRNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$34.0MSep ’24−$36.5MDec ’24−$46.8MMar ’25−$61.7MJun ’25−$65.7MSep ’25$33.0MDec ’25−$76.0MMar ’26−$106.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on file−$52.6M−$102.8M−$158.2M−$176.6M
Net incomenone on file−$51.3M−$89.6M−$122.5M−$141.2M
Operating cash flownone on file−$46.1M−$79.5M−$116.6M−$222.2M
Free cash flownone on file−$46.3M−$81.7M−$117.9M−$225.8M
Cash$105.3M$26.1M$129.8M$169.5M$799.6M
Shares outstandingnone on file10.5M139.2M171.9M212.5M